The American Journal of Medicine
Volume 115, Issue 5 , Pages 382-389 , 1 October 2003

Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease

  • Cynthia A Yock, MS

      Affiliations

    • Center for Primary Care and Outcomes Research (CAY, DKO, AMG), Stanford University School of Medicine, Stanford, California, USA
    • ,
  • Derek B Boothroyd, PhD

      Affiliations

    • Department of Health Research and Policy (DBB, DKO, AMG, MAH), Stanford University School of Medicine, Stanford, California, USA
    • ,
  • Douglas K Owens, MD, MS

      Affiliations

    • Center for Primary Care and Outcomes Research (CAY, DKO, AMG), Stanford University School of Medicine, Stanford, California, USA
    • Department of Health Research and Policy (DBB, DKO, AMG, MAH), Stanford University School of Medicine, Stanford, California, USA
    • Veterans’ Administration Health Care System (DKO, AMG), Palo Alto, California, USA
    • ,
  • Alan M Garber, MD, PhD

      Affiliations

    • Center for Primary Care and Outcomes Research (CAY, DKO, AMG), Stanford University School of Medicine, Stanford, California, USA
    • Department of Health Research and Policy (DBB, DKO, AMG, MAH), Stanford University School of Medicine, Stanford, California, USA
    • ,
  • Mark A Hlatky, MD

      Affiliations

    • Department of Health Research and Policy (DBB, DKO, AMG, MAH), Stanford University School of Medicine, Stanford, California, USA
    • Veterans’ Administration Health Care System (DKO, AMG), Palo Alto, California, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Mark A. Hlatky, MD, Stanford University School of Medicine, HRP Redwood Building, Room 150, Stanford, California 94305-5405, USA

Received 1 November 2002 ,Accepted 27 February 2003.

References 

  1. Weintraub WS, Craver JM, Jones EL, et al.  Improving cost and outcome of coronary surgery. Circulation. 1998;98(19 suppl):1123–1128
  2. Ferguson TBJ, Hammill BG, Peterson ED, et al.  A decade of change—risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999 (a report from the STS National Database Committee and the Duke Clinical Research Institute). Ann Thorac Surg. 2002;73:480–489
  3. Puskas JD, Thourani VH, Marshall J, et al.  Clinical outcomes, angiographic patency, and resource utilization in 200 consecutive off-pump coronary bypass patients. Ann Thorac Surg. 2001;71:1477–1484
  4. Cameron A, David KB, Green G, et al.  Coronary bypass surgery with internal-thoracic-artery grafts (effects on survival over a 15-year period). N Engl J Med. 1996;334:216–219
  5. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators . Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217–225
  6. Weintraub WS, Mahoney EM, Ghazzal ZM, et al.  Trends in outcome and costs of coronary intervention in the 1990’s. Am J Cardiol. 2001;88:497–503
  7. Seshadri N, Whitlow PL, Acharya N, et al.  Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation. 2002;106:2346–2350
  8. Califf RM. Restenosis (the cost to society). Am Heart J. 1995;130:680–684
  9. Fischman DL, Leon MB, Baim DS, et al.  A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Investigators. N Engl J Med. 1994;331:496–501
  10. Benestent Study Group Serruys PW, de Jaegere P, Kiemeneij F, et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489–495
  11. Babapulle MN, Eisenberg MJ. Coated stents for the prevention of restenosis (part II). Circulation. 2002;106:2859–2866
  12. Serruys PW, Degertekin M, Tanabe K, et al.  Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesion) trial. Circulation. 2002;106:798–803
  13. Weintraub WS, Mauldin PD, Becker E, et al.  A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). Circulation. 1995;92:2831–2840
  14. The Bypass Angioplasty Revascularization Investigators . Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol. 2000;35:1122–1129
  15. Feit F, Brooks MM, Sopko G, et al.  Long-term clinical outcome in the bypass angioplasty revascularization investigation registry. Comparison with the randomized trial. Circulation. 2000;101:2795–2802
  16. King SB, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS. Eight-year mortality in the Emory Angioplasty Versus Surgery Trial (EAST). J Am Coll Cardiol. 2000;35:1116–1121
  17. Serruys PW, Unger F, Sousa JE, et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117–1124
  18. The SoS Investigators . Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial) (a randomised controlled trial). Lancet. 2002;360:965–970
  19. Anderson HV, Shaw RE, Brindis RG, et al.  A contemporary overview of percutaneous coronary interventions. J Am Coll Cardiol. 2002;39:1096–1103
  20. Holmes DR, Gersh BJ. And the answer is, it doesn’t much matter. Circulation. 2002;106:11–13
  21. Bhatt DL, Topol EJ. Debate (PCI or CABG for multivessel disease? Viewpoint: no clear winner in an unfair fight). Curr Control Trials Cardiovasc Med. 2001;2:260–262
  22. Bourassa MG, Roubin GS, Detre KM, et al.  Bypass Angioplasty Revascularization Investigation (patient screening, selection and recruitment). Am J Cardiol. 1995;75:3C–8C
  23. Yock CA, Boothroyd DB, Owens DK, Winston C, Hlatky MA. Projected long-term costs of coronary stenting in multivessel coronary disease based on the experience of the Bypass Angioplasty Revascularization Investigation (BARI). Am Heart J. 2000;140:556–564
  24. Hlatky MA, Boothroyd DB, Brooks MM, et al.  Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty. Am Heart J. 1999;138(2 pt 1):376–383
  25. Hlatky MA, Rogers WJ, Johnstone I, et al.  Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med. 1997;336:92–99
  26. Hlatky MA, Boothroyd DB, Johnstone IM. Economic evaluation in long-term clinical trials. Stat Med. 2002;21:2879–2888
  27. Melsop KA, Boothroyd DB, Hlatky MA. Quality of life and time trade-off utility measures in patients with coronary artery disease. Am Heart J. 2003;145:36–41
  28. Gold MR, Siegel JE, Russell LB, Weinstein MC. In: Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996;p. 425
  29. Mathew V, Garratt K, Holmes DJ. Clinical outcome after multivessel coronary stent implantation. Am Heart J. 1999;138:1105–1110
  30. Antoniucci D, Valenti R, Santoro GM, et al.  Restenosis after coronary stenting in clinical practice. Am Heart J. 1998;135:510–518
  31. Rodriguez A, Bernardi V, Navia J, et al.  Argentine Randomized Study (coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results). J Am Coll Cardiol. 2001;37:51–58
  32. George CJ, Baim DS, Brinker JA, et al.  One-year follow-up of the stent restenosis (STRESS I) study. Am J Cardiol. 1998;81:860–865
  33. Benestent Study Group Macaya C, Serruys PW, Ruygrok P, et al.  Continued benefit of coronary stenting versus balloon angioplasty (one-year clinical follow-up of Benestent Trial). J Am Coll Cardiol. 1996;27:255–261
  34. Sukin CA, Baim DS, Caputo RP, et al.  The impact of optimal stenting techniques on cardiac catheterization laboratory resource utilization and costs. Am J Cardiol. 1997;79:275–280
  35. Price survey. Stent prices expected to decline. Hosp Mater Manage. 2001;26:12–13
  36. Weintraub WS, Becker ER, Mauldin PD, et al.  Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty Versus Surgery Trials (EAST). Am J Cardiol. 2000;86:747–752
  37. Nease RF, Kneeland T, O’Connor GT, et al.  Variation in patient utilities for outcomes of the management of chronic stable angina. JAMA. 1995;273:1185–1190
  38. Fryback DG, Lawrence WF. Dollars may not buy as many QALYs as we think (a problem with defining quality-of-life adjustments). Med Decis Making. 1997;17:276–284
  39. Fryback DG, Dasbach EJ, Klein RR, et al.  The Beaver Dam Health Outcomes Study (initial catalog of health-state quality factors). Med Decis Making. 1993;13:89–102
  40. Tengs TO, Wallace A. One thousand health related quality of life estimates. Med Care. 2000;38:583–637
  41. Cohen DJ, Breall JA, Kalon KL, et al.  Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. Circulation. 1994;89:1859–1874
  42. Gibson CM, Kuntz RE, Nobuyoshi M, Rosner B, Baim DS. Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy. Validation of a lesion-based restenosis analysis. Circulation. 1993;87:1123–1129
  43. Myers WO, Blackstone EH, Davis K, Foster ED, Kaiser GC. CASS registry. Long-term surgical survival. J Am Coll Cardiol. 1999;33:488–498
  44. Cantor WJ, Peterson ED, Popma JJ, et al.  Provisional stenting strategies (systematic overview and implications for clinical decision-making). J Am Coll Cardiol. 2000;36:1142–1151
  45. LeFeuvre C, Bonan R, Cote G, et al.  Five- to ten-year outcome after multivessel percutaneous transluminal coronary angioplasty. Am J Cardiol. 1993;71:1153–1158
  46. Chen LC, Chen YH, Chan WL, et al.  Clinical and angiographic determinants of adverse cardiac events in patients with stent restenosis. Catheter Cardiovasc Interv. 2002;55:331–337
  47. Newman MF, Kirchner JL, Phillips-Bute B, et al.  Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395–402
  48. Hlatky MA, Bacon C, Boothroyd D, et al.  Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery. Circulation. 1997;96(9 suppl):II11–II14
  49. Van Dijk D, Jansen EW, Hijman R, et al.  Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery (a randomized trial). JAMA. 2002;287:405–412
  50. Garber AM. Advances in cost-effectiveness analysis of health interventions. In:  Culyer AJ,  Newhouse JP editor. Handbook of Health Economics. Vol 1:Amsterdam: Elsevier Science; 2000;p. 182–221
  51. Weintraub WS, Thompson TD, Culler S, et al.  Targeting patients undergoing angioplasty for thrombus inhibition. A cost-effectiveness and decision support model. Circulation. 2000;102:392–398
  52. Kimmel SE, Localio AR, Krone RJ, et al.  The effects of contemporary use of coronary stents on in-hospital mortality. J Am Coll Cardiol. 2001;37:499–504
  53. Cohen EA, Young W, Slaughter PA, et al.  Trends in clinical and economic outcomes of coronary angioplasty from 1992 to 1995 (a population-based analysis). Am Heart J. 1999;137:1012–1018
  54. Williams DO, Holubkov R, Yeh W, et al.  Percutaneous coronary intervention in the current era compared with 1985-1986. The National Heart, Lung, and Blood Institute Registries. Circulation. 2000;102:2945–2951

☆ Supported by Grant 15151 from the Robert Wood Johnson Foundation, Princeton, New Jersey, and by Grant HL-58324 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland.

PII: S0002-9343(03)00296-1

doi: 10.1016/S0002-9343(03)00296-1

The American Journal of Medicine
Volume 115, Issue 5 , Pages 382-389 , 1 October 2003

Article Tools

* Image Usage & Resolution